The Clorox Company (NYSE:CLX) Shares Sold by Westhampton Capital LLC

Westhampton Capital LLC decreased its position in shares of The Clorox Company (NYSE:CLX) by 2.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,797 shares of the company’s stock after selling 559 shares during the quarter. Clorox accounts for approximately 2.0% of Westhampton Capital LLC’s portfolio, making the stock its 11th largest holding. Westhampton Capital LLC’s holdings in Clorox were worth $3,877,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. Waldron Private Wealth LLC purchased a new position in shares of Clorox in the 3rd quarter valued at about $217,000. Eastern Bank acquired a new stake in Clorox in the third quarter valued at approximately $1,027,000. Sequoia Financial Advisors LLC grew its holdings in Clorox by 2.5% in the third quarter. Sequoia Financial Advisors LLC now owns 4,228 shares of the company’s stock valued at $689,000 after purchasing an additional 102 shares during the period. Carolina Wealth Advisors LLC purchased a new stake in shares of Clorox in the third quarter valued at approximately $48,000. Finally, Northwest Investment Counselors LLC raised its stake in shares of Clorox by 1.8% during the 3rd quarter. Northwest Investment Counselors LLC now owns 5,743 shares of the company’s stock worth $936,000 after buying an additional 100 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. TD Cowen started coverage on shares of Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 price target on shares of Clorox in a research note on Friday, September 6th. Finally, Wells Fargo & Company cut their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $150.14.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.51% of the stock is currently owned by company insiders.

Clorox Stock Performance

NYSE CLX opened at $159.23 on Wednesday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The firm has a market capitalization of $19.77 billion, a P/E ratio of 82.50, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The stock’s fifty day moving average is $159.96 and its two-hundred day moving average is $145.33. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. On average, research analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.06%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.